LON:MIG5 Maven Income and Growth VCT 5 Final Earnings Report GBX 27.20 0.00 (0.00%) As of 09/15/2026 ProfileEarnings History Maven Income and Growth VCT 5 EPS ResultsActual EPSGBX 0.13Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AMaven Income and Growth VCT 5 Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AMaven Income and Growth VCT 5 Announcement DetailsQuarterFinalDate3/12/2025TimeN/AConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Maven Income and Growth VCT 5 Earnings HeadlinesMaven Income and Growth VCT 5 (LON:MIG5) Stock Price Crosses Below 50 Day Moving Average - Time to Sell?September 15 at 3:20 AM | americanbankingnews.comMaven Income and Growth VCT 5 Expands Share Capital via Dividend Investment SchemeAugust 28, 2026 | tipranks.comNNVC on Alert: FDA Validation and Outperform Rating!NanoViricides (NYSE: NNVC) just landed FDA Rare Pediatric Disease Designation for NV-387 in Measles, adding to its existing Orphan Drug Designation and opening a path toward a Priority Review Voucher, assets that have recently sold for around 195 million dollars. Noble Capital Markets initiated coverage with an Outperform rating and a 6 dollar price target, citing NNVC's broad-spectrum nanoviricide technology and its potential across Measles, MPox, Smallpox, and Ebola, where a Phase II trial is advancing in the Democratic Republic of Congo.September 16 at 1:00 AM | Equiscreen (Ad)Maven Income and Growth VCT 5 Sets Interim Dividend and Adjusted NAV for Reinvestment SchemeAugust 19, 2026 | tipranks.comMaven Income and Growth VCT 5 Updates Share Capital After Buy-BackJuly 6, 2026 | tipranks.comMaven Income and Growth VCT 5 Cuts Share Count After Buy-BackJuly 3, 2026 | tipranks.comSee More Maven Income and Growth VCT 5 Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Maven Income and Growth VCT 5? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Maven Income and Growth VCT 5 and other key companies, straight to your email. Email Address About Maven Income and Growth VCT 5Maven Income and Growth VCT 5 (LON:MIG5) is a venture capital trust fund specializes in growth capital investment. It investments in shares and securities in smaller, unquoted United Kingdom companies and AiM/PLUS companies which meet the criteria for VCT qualifying investments.View Maven Income and Growth VCT 5 ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Marex Stock Doubles on Record Profits, But Can the Rally Continue?The Ultimate Cyber Shield: CrowdStrike Rises Past $2352 "Cheap for a Reason" Airline Stocks That May Be Worth the RiskMarketBeat's Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks RiskyCould Dave & Buster’s Capitulation Signal the Bottom Is Finally In?Navan's Strong Quarter Meets an AI Spending Reality Check3 Defense Stocks Riding the High-Energy Laser Boom Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/8/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
